Researchers from Chapel Hill, N.C.-based University of North Carolina, Portland-based Oregon Health & Science University, Greenville, N.C.-based East Carolina University and the American Cancer Society enrolled 4,002 participants between July 6, 2020, and Sept. 17, 2021, in a randomized study to observe colorectal screening rates.
Here are five takeaways from the study:
- Participants were ages 50-75, had an average risk of colorectal cancer and were not up to date with current colorectal screening recommendations.
- Half of the study participants were mailed screening outreach materials, including an at-home fecal immunochemical testing kit with instructions and return postage, in addition to receiving standard care. The other half of participants received only standard care.
- Of participants who were mailed at-home testing kits, 30% completed screening. Of participants who received standard care, 9.7% completed screening.
- Of those who received a positive result through at-home testing, 68.8% completed a follow-up colonoscopy within six months. Of those who received standard care, 44.4% completed a follow-up colonoscopy.
- Advanced colorectal neoplasia was detected in 1.4% of participants who received an at-home test and in 0.7% of patients who received standard care.
Read the full study here.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
